The bill adds a statutory category—“medically necessary food”—and requires federal health programs to cover those products and the supplies needed to administer them for specified digestive and inherited metabolic disorders. It embeds a detailed definition (listing product types and covered conditions), excludes certain diet-related products, and preserves stronger State laws.
This is a cross-program access statute: Medicare receives a new benefit with a fee-schedule payment rule, Medicaid and CHIP become required to cover these items (with timing and State-legislation exceptions), and FEHBP contracts must include coverage. The measure aims to reduce hospitalizations and dangerous substitutions by recognizing specialized formulas, vitamins, and individual amino acids as health-care items rather than ordinary grocery items.
At a Glance
What It Does
The bill defines “medically necessary food” in the Social Security Act and requires coverage of such foods and related equipment under Medicare, Medicaid, CHIP, and the Federal Employees Health Benefits Program. It also creates payment rules for Medicare (an 80% payment tied to a fee schedule) and preserves State laws that provide broader coverage.
Who It Affects
Directly affects beneficiaries with inherited metabolic and certain gastrointestinal disorders, suppliers of specialty formulas and medical foods, state Medicaid programs, and FEHBP carriers; it signals but does not compel private insurers to follow suit. It also requires CMS and other federal administrators to create coding, fee schedules, and implementation guidance.
Why It Matters
By moving medical foods from a discretionary benefit to a defined covered benefit in federal statutes, the bill changes entitlement baselines, constrains State waiver approaches to benefit design, and forces payers and providers to treat specialized nutrition as medically necessary therapy rather than optional nutrition.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The core of the bill is statutory: it inserts a new definition of “medically necessary food” into the Social Security Act and then ties that definition to coverage across federal programs. The definition covers specialized low‑protein products, amino‑acid preparations, modified fat preparations, formulas, vitamins, and individual amino acids when prescribed for people who cannot ingest, digest, absorb, or metabolize ordinary foods or who have special nutrient needs that cannot be managed by diet modification alone.
It explicitly requires medical direction and supervision and excludes general risk‑reduction foods, diabetes dietary products, and gluten‑free items marketed for celiac/non‑celiac sensitivity.
For Medicare, the bill amends the benefits list to include medically necessary food and requires CMS to establish a fee schedule; Medicare payment is set at 80% of the lesser of actual charge or the fee‑scheduled amount. That change comes into force three years after enactment, allowing time for fee‑schedule development but delaying access for Medicare beneficiaries in the near term.
For Medicaid, the bill requires States to cover medically necessary food as a mandatory benefit, amends cost‑limit language to include related equipment and supplies, and prohibits benchmark plans from omitting this coverage; those changes take effect after two years, with an explicit carve‑out for States that must pass implementing legislation.The bill also inserts the same coverage requirement into CHIP and FEHBP (both effective one year after enactment, again with a State‑legislation exception for CHIP). It includes a non‑preemption clause so States can maintain or expand stronger protections.
The text finishes with a “sense of Congress” urging private plans to provide similar coverage and a provision clarifying that combinations of medically necessary foods and associated supplies should be covered when prescribed together. Implementation work—coding, pharmacy vs. DME channeling, fee schedules, and beneficiary cost‑sharing—will fall to federal and State administrators.
The Five Things You Need to Know
The bill creates a statutory definition of “medically necessary food” with five required criteria and an explicit exclusions list (e.g.
diabetes management products and foods marketed as gluten‑free are excluded).
Medicare is required to cover medically necessary food and related administration supplies, with payment set at 80% of the lesser of actual charge or an HHS‑established fee schedule; that Medicare change becomes effective 3 years after enactment.
Medicaid must treat medically necessary food as a mandatory benefit and may not let benchmark or benchmark‑equivalent plans omit it; the Medicaid changes take effect 2 years after enactment, with a delay if State legislation is required. , CHIP and FEHBP are also required to include medically necessary food in coverage; CHIP’s requirement takes effect 1 year after enactment (subject to State‑legislation delays) and FEHBP applies to contract years beginning 1 year after enactment. , The statutory covered conditions list is specific: inherited metabolic disorders (including RUSP conditions, organic acid disorders, fatty acid oxidation disorders, amino acid disorders, urea cycle disorders, glycogen storage disorders), malabsorption conditions (e.g.
short bowel), food allergies (including FPIES and eosinophilic/eosinophillic disorders), and certain inflammatory/immune alimentary conditions (including IBD and GERD refractory to standard therapy).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Designates the Act’s name as the “Medical Foods and Formulas Access Act of 2025.” Mechanically short, but important because subsequent references and rulemakings will use that title.
Findings
Sets out the medical rationale and legislative intent—emphasizing pediatric vulnerabilities, the 2022 formula shortage experience, and that medically necessary food is often first‑line therapy. These findings have no operative effect but frame rulemaking and likely appear in Congressional reports; they will be used as interpretive guidance by agencies and courts to justify treating these products as health care rather than consumer goods.
Defines medically necessary food for Medicare and establishes payment
Amends section 1861 to add subsection (nnn), giving a specific, multi‑part definition that lists covered product types, prescriber‑based authorization, intended use (oral or enteral), and a nonexhaustive list of covered conditions. It then amends payments under section 1833 to require Medicare to pay 80% of the lesser of actual charge or an HHS fee schedule for these items. The Medicare coverage becomes operative three years after enactment, giving CMS time to create a fee schedule and billing guidance; however the statute leaves beneficiary cost‑sharing (the remaining 20% under Part A rules) in place, raising potential out‑of‑pocket issues.
Makes medically necessary food a Medicaid mandatory benefit and constrains benchmark designs
Adds ‘medically necessary food’ to the list of covered Medicaid items and makes related equipment and supplies explicitly includable under cost caps. It amends mandatory benefit language so States must offer these items and prohibits benchmark and benchmark‑equivalent plans from excluding them. The effective date is two years after enactment, but States get a statutory grace period if legislative change is needed. Practically, States must update their Medicaid plans and FMAP budgeting to accommodate new claims and reimbursement structures.
Requires State child health plans to include medically necessary food
Adds medically necessary food to the list of child health assistance services for targeted low‑income children under title XXI. The rule mirrors Medicaid’s coverage requirement but includes the same State‑legislation exception; it becomes effective one year after enactment, imposing a tighter timeline on State CHIP implementations than Medicaid.
Obligates FEHBP carriers to cover medically necessary food
Adds a contractual requirement that FEHBP carriers provide coverage for medically necessary food consistent with the new SSA definition. This applies to contract years beginning one year after enactment, meaning federal employees and retirees will gain coverage earlier than Medicare beneficiaries.
Nonbinding encouragement for private plans, nonpreemption, and coverage of combinations
Contains a nonbinding statement urging private insurers to adopt comparable coverage, a nonpreemption clause allowing States to retain or expand stronger protections, and a clarification that combinations of medically necessary foods and supplies should be covered when prescribed together. The nonpreemption language preserves State innovation but complicates uniform market practice.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Infants and children diagnosed through newborn screening and families of those children — the statute explicitly lists RUSP‑associated inherited metabolic disorders and aims to secure access to life‑sustaining formulas that can prevent hospitalization and neurologic injury.
- Adults and pediatric patients with short bowel syndrome, severe malabsorption, eosinophilic disorders, food protein‑induced enterocolitis syndrome, and refractory IBD — by treating specialized nutrition as a covered medical therapy, patients get a clearer entitlement and a prescribing pathway.
- Clinicians (pediatricians, metabolic specialists, gastroenterologists, dietitians) — gain statutory backing to prescribe nutritional therapies without the same barrier arguments from payers that treat formulas as nonmedical foods.
- Manufacturers and authorized distributors of specialty formulas, amino‑acid preparations, and nutritional vitamins — receive a predictable federal market demand signal across public programs, improving contracting and inventory planning, and reducing emergency substitute pressures.
Who Bears the Cost
- Medicare beneficiaries — the Medicare payment formula covers 80% through Medicare’s mechanism, meaning coinsurance and deductible exposure for beneficiaries could be substantial unless supplemental coverage steps in.
- State Medicaid programs and state budgets — making these items mandatory benefits will increase utilization and expenditures; States face actuarial and budget pressures, especially where prevalence is concentrated or product prices are high.
- Federal agencies and FEHB carriers — FEHBP carriers and the Office of Personnel Management must absorb new coverage obligations that may raise premiums or change plan design; FEHBP costs ultimately affect federal employers and taxpayers.
- Payers and plan administrators (private and public) — must develop billing codes, prior‑authorization rules, medical necessity criteria and supplier networks; that operational work is an upfront administrative cost and creates room for dispute litigation.
Key Issues
The Core Tension
The bill resolves an access problem—ensuring life‑sustaining, specialized nutrition is treated as health care—but creates a classic trade‑off between guaranteed access and fiscal/administrative burdens: guaranteeing coverage expands entitlement and clinical options but raises questions about who pays the recurring cost, how much beneficiaries will owe, and how to prevent scope creep where common dietary products are relabeled as “medical.”
The bill balances access with limited payment mechanics, but leaves several consequential operational questions unresolved. It requires Medicare to pay 80% of the lesser of actual charge or a fee‑scheduled amount, yet it does not change standard beneficiary cost‑sharing rules; absent regulatory action or supplemental coverage, patients could face large out‑of‑pocket bills for recurring, high‑cost formulas.
The staggered effective dates (FEHBP/CHIP at one year, Medicaid at two, Medicare at three) produce unequal timing of access across populations and could shift demand surges to programs with earlier effective dates.
The statutory definition is detailed but also creates interpretive levers and ambiguity. The Secretary retains authority to add “other products,” and the exclusion of glucose/diabetes products and gluten‑free products raises classification disputes at the pharmacy/DME boundary.
The bill does not explicitly forbid payer policies that require tube feeding rather than oral administration; the definition contemplates both oral and enteral delivery but does not prohibit insurers from preferring one route for cost or clinical reasons. Finally, implementation requires CMS, state Medicaid agencies, and FEHBP carriers to set codes, fee schedules, and prior‑authorization criteria—an administrative lift that will determine real‑world access and could produce litigation over medical necessity standards and reimbursement rates.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.